anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
AstraZeneca · conference-presentation

AstraZeneca | Results Presentation Deck | 39 slides

39 pages · 5 arc beats · 2 loops

Conference-Presentation Download JSON
Unlock

AstraZeneca | Results Presentation Deck | 39 slides

AstraZeneca · 2021-11
arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 2
— No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.
—

Deck intelligence map

5
coverage by narrative range · generated from this deck JSON
Narrative range 33 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Attention 6 slides 100% 6/6 slides 100% 6/6 slides · 36 hits
— 0/6 slides
16.7% 1/6 slides 16.7% 1/6 slides 100% 6/6 slides 16.7% 1/6 slides Need 7 slides 100% 7/7 slides 100% 7/7 slides · 31 hits
— 0/7 slides
42.9% 3/7 slides 14.3% 1/7 slides 100% 7/7 slides 100% 7/7 slides Satisfaction 7 slides 100% 7/7 slides 100% 7/7 slides · 46 hits
— 0/7 slides
— 0/7 slides
— 0/7 slides
100% 7/7 slides 100% 7/7 slides Visualization 7 slides 100% 7/7 slides 100% 7/7 slides · 47 hits
— 0/7 slides
57.1% 4/7 slides · 5 hits
— 0/7 slides
100% 7/7 slides
— 0/7 slides
Action 6 slides 100% 6/6 slides 100% 6/6 slides · 39 hits
— 0/6 slides
33.3% 2/6 slides 16.7% 1/6 slides 100% 6/6 slides
— 0/6 slides

Slide inventory

39
every slide · same image gating as the playbook
01
Slide 1
front_matter
Open slide detailBeat · Attention
02
other
Open slide detailBeat · Attention
03
introduce_nominees
Open slide detailBeat · Attention
04
front_matter
Open slide detailBeat · Attention
05
front_matter
Open slide detailBeat · Attention
06
The slide uses a three-column layout to categorize performance metrics and clinical milestones.summarize
Open slide detailBeat · AttentionLoop · Logic Chain
07
The slide uses two side-by-side tables to segment revenue performance by therapeutic area and geography, excluding COVID-19 vaccine in the geographic breakdown.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
08
The slide uses a table to categorize pipeline progress into regulatory approvals, submissions, and clinical data readouts.summarize
Open slide detailBeat · NeedLoop · Logic Chain
09
transition
Open slide detailBeat · NeedLoop · Logic Chain
10
Includes footnotes regarding exchange rates, definitions of line items, and pandemic vaccine impact.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
11
Includes footnotes regarding CER, R&D, SG&A, and EPS impact.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
12
The chart shows a stacked bar trend with a yellow trend arrow. The guidance section uses text boxes to summarize financial targets.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
13
The slide uses a waterfall chart to bridge net debt figures and lists strategic priorities for capital allocation.analyze_data
Open slide detailBeat · NeedLoop · Logic Chain
14
The slide uses a stylized human silhouette with cellular imagery, likely representing cancer research or treatment.transition
Open slide detailBeat · SatisfactionLoop · Golden Circle
15
The slide uses stacked bar charts to show revenue composition by region (US, Europe, ERoW, EM) over time, accompanied by qualitative commentary on regional perfanalyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
16
Includes footnotes defining acronyms and collaboration revenue components.analyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
17
Slide 17 of a presentation; includes product imagery and specific clinical acronym definitions in the footer.analyze_data
Open slide detailBeat · SatisfactionLoop · Golden Circle
18
Includes a Kaplan-Meier survival curve for the DESTINY-Breast03 trial.summarize
Open slide detailBeat · SatisfactionLoop · Golden Circle
19
Includes a footnote defining STRIDE regimen.summarize
Open slide detailBeat · SatisfactionLoop · Golden Circle
20
The slide uses a split layout to contrast 'What's next' (early pipeline) with 'What's now' (Phase III/lifecycle).present_solution
Open slide detailBeat · SatisfactionLoop · Golden Circle
21
transition
Open slide detailBeat · Visualization
22
Includes a stacked bar chart for Farxiga revenue by region and a line chart for Lokelma US market share.analyze_data
Open slide detailBeat · Visualization
23
Includes product-specific performance metrics and regional/market share drivers.analyze_data
Open slide detailBeat · Visualization
24
The chart uses a stacked bar format to distinguish between China, Ex-China EMs, and COVID-19 vaccine sales.analyze_data
Open slide detailBeat · Visualization
25
Includes product-specific status updates for three key assets.summarize
Open slide detailBeat · Visualization
26
The slide uses a three-column layout to compare three distinct therapeutic assets.summarize
Open slide detailBeat · Visualization
27
The slide uses a split-layout to contrast 'What's next' (early stage) with 'What's now' (late stage).present_solution
Open slide detailBeat · Visualization
28
Slide 5 of a presentation deck.transition
Open slide detail
29
The slide uses a three-column structure to summarize the value proposition of the rare disease segment.summarize
Open slide detail
30
The slide uses an icon-grid layout to represent strategic focus areas for collaboration.present_framework
Open slide detail
31
The slide contrasts financial performance (bar chart) with clinical development milestones (bulleted list).analyze_data
Open slide detail
32
Includes patient photos and disease-specific context.analyze_data
Open slide detail
33
The slide uses a split layout to contrast 'What's next' (Phase I/II) with 'What's now' (Phase III).plan_implementation
Open slide detail
34
Slide number 6 is displayed in a circle.state_next_steps
Open slide detailBeat · Action
35
The slide uses color coding for drug categories: Oncology (purple), BioPharmaceuticals (blue), and Rare Disease (red).plan_implementation
Open slide detailBeat · Action
36
The slide serves as a transition to the Q&A session, identifying the leadership team available to answer questions.other
Open slide detailBeat · Action
37
appendix
Open slide detailBeat · Action
38
other
Open slide detailBeat · Action
39
other
Open slide detailBeat · Action